参附注射液不同剂量治疗缓慢性心律失常心阳虚证疗效的临床观察  

Clinical observation on treating arrhythmia of Xinyang deficiency with Shenfu injection of different doses

作　　者：吴慧颖[1] 

机构地区：[1]商丘市第一人民医院,河南商丘476000

出　　处：《中医临床研究》2013年第18期78-79,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的：研究采用不同剂量的注射液治疗缓慢性心律失常心阳虚证的治疗效果。方法：选择我院在2011年12月～2012年12月收治的80例缓慢性心率失常心阳虚证患者，随机分为观察组和对照组。观察组患者使用参附注射液100mL，对照组患者使用参附注射液50ml，观察对比两组患者在治疗缓慢性心律失常的总治疗效果。结果：两组患者在治疗后心率都相比于治疗前有明显的提升（P0.05），但无统计学意义。观察组患者治疗缓慢性心律失常的治疗效果明显高于对照组（P〈0.05），差异具有统计学意义。结论：对于缓慢性心率失常患者使用参附注射液100mL能够体现出整体调节的优势，安全有效，无副作用发生，值得在临床上广泛应用。Objective：To study the effect of different doses of injection on treating arrhythmia Xinyang deficiency. Methods：From December 2011 to December 2012 of our hospital, 80 cases of chronic arrhythmias of Xinyang deficiency syndrome were randomly divided into observation group and control group. The patients of observation group were treated with 100ml Shenfu, the patients of control group were treated with 50ml Shenfu. To observe and compare two groups of patients in the treatment of arrhythmia overall. Results：The patients in heart rate after treatment compared to before treatment were significantly improved （P0.05）, but had not statistically significance. Arrhythmia treatment effect of observation group was significantly higher （P〈0.05）, a statistically significant difference. Conclusion： For patients with chronic arrhythmias, 100ml Shenfu adjusted to reflect an overall advantage, safe and effective, no side effects, it is worthy of wide clinical practice.

关 键 词：参附注射液 缓慢性心律失常 心阳虚证 

分 类 号：R541.7[医药卫生—心血管疾病]